Long-term use of adalimumab in the treatment of rheumatic diseases. - Wikidata - awgldk - TriplyDB

Long-term use of adalimumab in the treatment of rheumatic diseases.

Long-term use of adalimumab in the treatment of rheumatic diseases.

http://www.wikidata.org/entity/Q37358124

about

Long-term use of adalimumab in the treatment of rheumatic diseases.

http://www.wikidata.org/entity/Q37358124

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Long-term use of adalimumab in the treatment of rheumatic diseases.

@en

Long-term use of adalimumab in the treatment of rheumatic diseases.

@nl

type

label

Long-term use of adalimumab in the treatment of rheumatic diseases.

@en

Long-term use of adalimumab in the treatment of rheumatic diseases.

@nl

prefLabel

Long-term use of adalimumab in the treatment of rheumatic diseases.

@en

Long-term use of adalimumab in the treatment of rheumatic diseases.

@nl

P1433

Q37358124-2E4CB6F0-B173-429F-BD14-83A6802D3BC9

P1476

Q37358124-2D05670F-04CD-4F93-9F7E-98345164470D

P2093

Q37358124-5A3A9D78-3BFB-4BBD-856F-12B6F932B02C

Q37358124-B965D7EC-11B3-467C-B19D-015E7C56A6C9

P2860

Q37358124-020BE3DD-8F97-4B76-AACF-2E520D82E615

Q37358124-08D1C0C3-AA16-495B-B4FB-F708CCFC8128

Q37358124-12B033F4-0B33-46F5-B674-9683D8B42F82

Q37358124-19DD75DB-8DD4-4234-96F8-7D7358856904

Q37358124-20D81B7C-E8DA-4AC8-A1B6-25C5E360A5FA

Q37358124-21F3CF78-F22B-4794-B5A0-6BBADE0A3473

Q37358124-22C0FBE5-F847-4ADD-97A2-F3974FE22D91

Q37358124-252BD3DF-AA27-4A70-B9AA-8D98384E5B4F

Q37358124-279993A6-C30D-4A18-9C65-A9D934F919AB

Q37358124-2951CAED-58AE-4582-8DF7-FA67ABA1F9C3

P304

Q37358124-BDB6F14E-B07B-4F30-9446-A0B49C28B92E

P31

Q37358124-A920BB53-1C0B-4831-8871-A3C93DA730D1

P356

Q37358124-F97059EA-1267-4328-9DAC-8F1DC682B2AA

P478

Q37358124-92FF82B6-435C-4536-B985-F33998330AD4

P50

Q37358124-169B165A-9465-4D67-A464-3FC067E1A203

P577

Q37358124-E3C873B8-B916-44B1-8A44-10A64FCB1AD3

P698

Q37358124-08063FEC-8F6E-4878-A857-12C9338B133E

P921

Q37358124-EA8DFD45-E8C7-471C-8F4A-37B501D33A8F

P932

Q37358124-C50D782E-D640-42DC-8620-1CAEA81ED5D1

P356

P1433

Open Access Rheumatology: Research and Reviews

P1476

Long-term use of adalimumab in the treatment of rheumatic diseases

@en

P2093

Alexandros A Drosos

http://www.w3.org/2001/XMLSchema#string

Paraskevi V Voulgari

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.

Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies.

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with c

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

Adalimumab with or without methotrexate in juvenile rheumatoid arthritis.

Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis.

P304

51-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OARRR.S4297

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Charalampos Papagoras

P577

2009-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27789981

http://www.w3.org/2001/XMLSchema#string

P921

P932

5074727

http://www.w3.org/2001/XMLSchema#string